Bionano Genomics Inc BNGO:NASDAQ

Last Price$2.00NASDAQ Closing Price as of 3:59PM ET 12/05/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.09(4.31%)
Bid (Size)$2.01 (78)
Ask (Size)$2.02 (26)
Day Low / High$1.98 - 2.17
Volume6.9 M
 

View Biotechnology IndustryPeer Comparison as of 12/05/2022

 

Bionano Genomics Inc ( NASDAQ )

Price: $2.00
Change: -0.09 (4.31%)
Volume: 6.9 M
3:59PM ET 12/05/2022
 
 

MaxCyte Inc ( NASDAQ )

Price: $5.42
Change: -0.66 (10.86%)
Volume: 308.8 K
3:59PM ET 12/05/2022
 
 

Sangamo Therapeutics Inc ( NASDAQ )

Price: $3.54
Change: -0.11 (3.15%)
Volume: 1.2 M
4:00PM ET 12/05/2022
 
 

Sorrento Therapeutics Inc ( NASDAQ )

Price: $1.18
Change: -0.08 (6.35%)
Volume: 13.0 M
4:00PM ET 12/05/2022
 
 

ADMA Biologics Inc ( NASDAQ )

Price: $3.24
Change: -0.12 (3.57%)
Volume: 2.4 M
4:00PM ET 12/05/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery
4:01PM ET 11/29/2022 MT Newswires

Health care stocks were ending narrowly lower Tuesday afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both...

Sector Update: Health Care Stocks Still Underwater in Tuesday Trade
1:49PM ET 11/29/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 0.4% and the SPDR Health Care Select Sector ETF (XLV) down...

Sector Update: Health Care
1:41PM ET 11/29/2022 MT Newswires

Health care stocks were mostly lower Tuesday afternoon, with the NYSE Health Care Index slipping 0.4% while the SPDR Health Care Select Sector ETF (XLV)...

Bionano Genomics to Acquire Purigen Biosystems for up to $64 Million; Shares up After Hours
5:25PM ET 11/28/2022 MT Newswires

Bionano Genomics (BNGO) said late Monday it has agreed to acquire Purigen Biosystems for up to $64 million. The deal consideration includes $32 million in...

Company Profile

Business DescriptionBionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA. View company web site for more details
Address9540 Towne Centre Drive
San Diego, California 92121
Phone+1.858.888.7600
Number of Employees77
Recent SEC Filing11/30/20228-K
President, CEO, Secretary & DirectorRobert Erik Holmlin
Chief Operating OfficerMark Oldakowski
Chief Financial & Accounting OfficerChristopher Stewart
Chief Medical OfficerAlka Chaubey

Company Highlights

Price Open$2.16
Previous Close$2.09
52 Week Range$1.16 - 4.35
Market Capitalization$593.8 M
Shares Outstanding296.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/07/2023

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.41
Beta vs. S&P 500N/A
Revenue$12.0 M
Net Profit Margin-451.42%
Return on Equity-38.48%

Analyst Ratings as of 05/06/2022

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset